Core Insights - The company, Zhejiang Tailin Biotechnology Co., Ltd., held a specific investor survey on November 3, 2025, with participation from 18 institutions including Everbright Securities and Hangzhou Zheyun Private Equity [1][2]. Company Overview - Tailin Biotechnology was listed on the Shenzhen Stock Exchange's Growth Enterprise Market in January 2020, focusing on technological innovation and product development in fields such as biotechnology, precision medicine, pharmaceutical engineering, food safety, and new materials [3]. Key Issues Addressed - Semiconductor Industry Application: The company has received orders for TOC products, with a focus on expanding their application in the semiconductor industry as a key development direction for the year [4]. - Water Ecology Market: The market is shifting towards data-driven and precise demands, with the company’s products addressing systemic needs in water monitoring and safety management [4]. - High-Performance Filter Project: The subsidiary has secured land use rights for the project, with preliminary work progressing as planned [4]. - Gross Margin Improvement: The increase in gross margin is attributed to the rise in the contribution from sterile production equipment and significant growth in international markets [4]. - R&D Focus: The company is concentrating R&D expenses on three main areas: life sciences, medical engineering, and analytical instruments, with recent emphasis on five key fields including water ecology detection and semiconductor applications [4].